| 1/4 | US=85 / Biol/Mol Wandl S, Wesierska-Gadek J. Is olomoucine, a weak CDK2 inhibitor, able to induce apoptosis in cancer cells?. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 242-9. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. CDKS; G1; FARMACOLOGICA CDK2 INIBIDOR; G1 PRISAO; PARADA DO CICLO CELULAR; SUPRESSOR DE TUMOR P53; APOPTOSE |
| 2/4 | US=85 / Biol/Mol Wandl S, Wesierska-Gadek J. Is olomoucine, a weak CDK2 inhibitor, able to induce apoptosis in cancer cells?. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 242-9. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. CDKS; FARMACOLOGICA CDK2 INIBIDOR; SUPRESSOR DE TUMOR P53; APOPTOSE; PRIVACAO DE SORO; PARADA DO CICLO CELULAR |
| 3/4 | US=77-J / Câncer Costa ET, Asprino PF. Ciclo celular. In: Lopes A, Chammas R, Iyeyasu H. Oncologia para a graduação. 3ª ed. São Paulo: Lemar, 2013. p. 96-104. ISBN 8-5866523-7-0. |
| 4/4 | US=12-C / Biol/Mol Alberts B, Bray D, Hopkin K, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Controle do ciclo celular e morte celular. In: ___. Fundamentos da biologia celular. 2ª ed. Porto Alegre: Artmed, 2006. p. 611-36. ISBN 85-3630679-7. CICLO CELULAR; MORTE CELULAR; CICLINAS; CDKS; MORTE CELULAR PROGRAMADA; APOPTOSE |